BC3195
Locally Advanced or Metastatic Solid Tumors
Phase 1In combination trial with KEYTRUDA (collab started Mar 2025)
Key Facts
Indication
Locally Advanced or Metastatic Solid Tumors
Phase
Phase 1
Status
In combination trial with KEYTRUDA (collab started Mar 2025)
Company
About BioCity Biopharma
A clinical-stage biopharma developing novel BIC/FIC therapeutics for oncology and nephrology, with a multi-modality pipeline and global clinical operations.
View full company profileTherapeutic Areas
Other Locally Advanced or Metastatic Solid Tumors Drugs
| Drug | Company | Phase |
|---|---|---|
| Systemic DNase I | Xenetic Biosciences | Preclinical |
| AVS100 | Avstera Therapeutics | Phase 1 |
| UGN-401 | UroGen Pharma | Phase 1/2 |